Advertisement

Advertisement

LPCN Stock Latest News

Lipocine price target lowered to $6 from $11 at Alliance Global

The FlyLipocine price target lowered to $6 from $11 at Alliance Global

Lipocine downgraded to Neutral from Buy at H.C. Wainwright

PremiumThe Fly

Lipocine downgraded to Neutral from Buy at H.C. Wainwright

11d ago

Lipocine weighs path after LPCN 1154 Phase 3 miss

PremiumCompany Announcements

Lipocine weighs path after LPCN 1154 Phase 3 miss

15d ago

Lipocine Updates Investor Presentation to Refine Market Messaging

PremiumCompany Announcements

Lipocine Updates Investor Presentation to Refine Market Messaging

15d ago

Lipocine’s LPCN 1154 did not meet endpoint in postpartum depression trial

PremiumThe Fly

Lipocine’s LPCN 1154 did not meet endpoint in postpartum depression trial

15d ago

Lipocine price target raised to $11 from $6.75 at Alliance Global

PremiumThe FlyLipocine price target raised to $11 from $6.75 at Alliance Global

1M ago

Lipocine Files Prospectus to Enable $50M Stock Offering

Company Announcements

Lipocine Files Prospectus to Enable $50M Stock Offering

1M ago

LPCN Upcoming Earnings Report: What to Expect?

Pre-Earnings

LPCN Upcoming Earnings Report: What to Expect?

2M ago

Lipocine Completes Phase 3 Trial for Postpartum Depression

PremiumCompany Announcements

Lipocine Completes Phase 3 Trial for Postpartum Depression

2M ago

Lipocine Updates Investor Presentation to Reflect Latest Strategy

PremiumCompany Announcements

Lipocine Updates Investor Presentation to Reflect Latest Strategy

2M ago

Lipocine announces last patient visit in Phase 3 trial of LPCN 1154

PremiumThe Fly

Lipocine announces last patient visit in Phase 3 trial of LPCN 1154

2M ago

Lipocine price target raised to $15 from $7 at H.C. Wainwright

PremiumThe Fly

Lipocine price target raised to $15 from $7 at H.C. Wainwright

3M ago

Lipocine Completes Phase 3 Enrollment for Postpartum Depression Drug

PremiumCompany AnnouncementsLipocine Completes Phase 3 Enrollment for Postpartum Depression Drug

3M ago

Lipocine completes enrollment, dosing in Phase 3 trial of LPCN 1154

The Fly

Lipocine completes enrollment, dosing in Phase 3 trial of LPCN 1154

3M ago

Lipocine updates investor presentation and corporate materials

Company Announcements

Lipocine updates investor presentation and corporate materials

3M ago

Lipocine Advances Phase 3 Postpartum Depression Drug Trial

PremiumCompany Announcements

Lipocine Advances Phase 3 Postpartum Depression Drug Trial

3M ago

Lipocine: DSMB recommended Phase 3 LPCN 1154 continue as planned

PremiumThe Fly

Lipocine: DSMB recommended Phase 3 LPCN 1154 continue as planned

3M ago

Lipocine Advances Phase 3 Trial for PPD Treatment

PremiumCompany Announcements

Lipocine Advances Phase 3 Trial for PPD Treatment

4M ago

Lipocine ‘s PPD Phase 3 study hits 80% enrollment milestone

PremiumThe Fly

Lipocine ‘s PPD Phase 3 study hits 80% enrollment milestone

4M ago

Lipocine Showcases LPCN 2101 at Epilepsy Meeting

PremiumCompany AnnouncementsLipocine Showcases LPCN 2101 at Epilepsy Meeting

4M ago

Lipocine Announces Positive Interim Results for PPD Trial

Company Announcements

Lipocine Announces Positive Interim Results for PPD Trial

5M ago

Lipocine Updates Corporate Presentation for Investors

Company Announcements

Lipocine Updates Corporate Presentation for Investors

5M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >